Exenatide, an injectable peptide currently in phase two clinical trials for treating type 2 diabetes, reduces symptoms of Idiopathic Intercranial Hypertension blinding headaches, a new study reports.
Using oral transmucosal delivery of eletriptan hydrobromide delivers faster and more effective relief for migraine sufferers.
Fatigue and headaches top the list of common lingering symptoms four months after COVID infection, with muscle aches, changes in sense of taste and smell, cough, and congestion following close behind.
Six months following COVID-19 infection, two-thirds of patients still experienced neurological symptoms including headaches, memory impairment, and decreased concentration that impacted their quality of life.
People with asymmetrical brain arteries have a significantly higher risk of developing a cerebral aneurysm, a new study reports.
Neurological and psychological symptoms associated with COVID-19 infection, such as fatigue and depression, are more common in those with mild coronavirus infection than previously believed.
Initially believed to be an acoustic attack, researchers now believe they have pinpointed a possible cause of the bizarre neurological symptoms reported by diplomats in Cuba in 2016. Researchers say a possible source for 'Havana syndrome' is exposure to cholinesterase inhibitors via organophosphorus insecticides.
Researchers have identified a positive association between persistent lower back pain and headache disorders. The study reveals those with persistent back pain or persistent headache disorders are twice as likely to suffer from both disorders at the same time.
Many people who suffer migraines are often diagnosed with other conditions. For those with a clinical diagnosis, many are unaware of treatment options available for pain and to slow the frequency of attacks.
Drinking three or more cups of coffee a day can trigger the onset of a headache for patients with episodic migraines.
The loss of TRESK significantly increases the risk of developing headaches and may be implicated in migraines.
An immunotherapy that acts against an inflammatory molecule associated with migraines, has been shown to be successful in reducing the number of headaches people with chronic migraines suffer each month.
